This audit is for higher specialty trainees choosing a primary bank for the SCE in Palliative Medicine who want to know what StudyPRN actually tests before they commit. It examines the single written best-of-five paper the SCE consists of. The headline: StudyPRN is one of the few vendors that genuinely covers this niche exam, which is a real strength — but a standard multiple-choice bank has structural blind spots around calculations, ethics and formulary nuance that you must close deliberately, whichever bank you buy.
What StudyPRN offers for SCE Palliative Medicine right now
| Item | Detail (vendor-reported, checked 20 July 2026) |
|---|---|
| Product | Palliative Medicine SCE question bank |
| Question count | 599 questions, including a 100-question, 3-hour mock (vendor-reported) |
| Access period | Subscription tiers of 3, 6 and 12 months |
| Price | From around £199 for 3 months (vendor-reported) |
| Adaptive/AI features | None described; instant feedback, frequently updated content, peer comparison, online notes, unlimited resits, CPD certificate |
| Components supported | The written SCE paper only |
| Last checked | 20 July 2026 |
StudyPRN's dedicated SCE catalogue is a genuine advantage for an exam this specialised — general medical banks rarely give palliative medicine more than a passing nod, so a purpose-built bank of this size is worth taking seriously. All figures are vendor-reported and move; confirm the current count, mock inclusion, access window and price on the StudyPRN product page. There is no adaptive engine described, so coverage discipline remains your responsibility.
Exam anchor: the SCE format and the Palliative Medicine blueprint
The SCE structure is fixed: two papers of 100 best-of-five questions, 200 total, three hours each, one day, Surpass-based, one mark per correct answer, no negative marking. The Federation's 2023 Palliative Medicine blueprint distributes the 200 marks like this:
| Blueprint domain | Questions | Share |
|---|---|---|
| Other symptoms/clinical problems secondary to life-limiting disease | 48 | 24% |
| Pharmacology and therapeutics | 35 | 17.5% |
| Management of life-limiting disease | 20 | 10% |
| Clinical problems unrelated to cancer | 20 | 10% |
| Management of emergencies | 20 | 10% |
| Care of the dying patient and their family | 20 | 10% |
| Pain (assessment and management) | 15 | 7.5% |
| Legal issues | 15 | 7.5% |
| Practical procedures | 5 | 2.5% |
| Rehabilitation | 2 | 1% |
This official weighting is the yardstick for the audit that follows. A bank's headline total tells you nothing until you break it down against these shares.
Break the headline count down by blueprint domain
A bank of 599 questions sounds ample, but the number that matters is the per-domain count, not the total. Before you rely on StudyPRN, tabulate roughly how many of its questions fall into each blueprint domain and compare that against the official shares. The two heavy domains — symptom control secondary to life-limiting disease (24%) and pharmacology and therapeutics (17.5%) — should dominate; if a bank over-invests in pain or care of the dying at the expense of the 24% symptom-control domain, its balance is off even if the total is large. Build this as a blueprint-coverage matrix rather than trusting the front-page number.
Sample question style: recall versus application
Audit a stratified sample of the bank for cognitive level. The SCE rewards application — interpreting a clinical picture and choosing the next step — more than bare recall. Check stem length (are they realistic vignettes or one-line factoids?), option plausibility (are the distractors credible, or is one answer obviously right?), and whether questions demand management sequencing ("what is the most appropriate next step?") rather than simple identification. Some data and image interpretation is fair game — a blood film in hypercalcaemia, an imaging finding in cord compression — so note whether the bank includes it. A bank skewed toward recall will flatter your first pass and leave you under-rehearsed for the reasoning the real paper demands.
Jurisdiction and recency: check a sample against current guidance
Palliative practice guidance changes, and a bank is only as good as its last update. Take a stratified sample and check it against current UK sources — NICE guidance on care of the dying adult and on the management of specific symptoms, SIGN and CKS, and the SmPC/eMC for drug-level detail. Confirm that anticipatory prescribing, opioid choice and conversion, and emergency management reflect current UK practice rather than older conventions. Record the date you did this review, because "the bank looked current in July 2026" is a claim with a shelf life. Where a vendor states content is "frequently updated", treat that as a vendor claim to verify, not a guarantee.
Common blind spots to check the bank covers
Three areas are commonly under-served by palliative banks and worth auditing specifically. Non-malignant life-limiting disease — advanced heart failure, end-stage COPD, chronic kidney disease and neurodegenerative conditions such as motor neurone disease — maps to the 10% "clinical problems unrelated to cancer" domain, yet many banks skew heavily toward cancer. Younger-adult scenarios and the interface with specialist services are easily missed. And distinguishing a reversible palliative emergency from expected dying — a spinal cord compression worth treating versus the final hours of life — is conceptually demanding and thinly covered. Sample the bank against these three and note where you will need source reading to fill them.
Format gap: what a Q-bank cannot fully prepare you for
State this plainly: a standard multiple-choice bank, StudyPRN included, only partly prepares you for three things the palliative blueprint leans on.
- Symptom-control calculations — opioid dose conversions, breakthrough dosing, syringe-driver arithmetic. A bank can test the endpoint, but you need fluent, repeated calculation practice to avoid the single-step error that changes the answer.
- Ethics and law — capacity assessment under the Mental Capacity Act, best-interests decisions, advance decisions to refuse treatment, DNACPR and ReSPECT. Multiple-choice items can probe these, but the reasoning is best consolidated against primary guidance.
- Formulary nuance — the drug-level detail that underpins safe symptom control is grounded in the SmPC/eMC and specialist palliative care guidance, and no bank substitutes for reading the source when a question exposes a gap.
Knowing where the format itself is a limitation is more useful than any single question.
Duplication and contamination: recognition creeping in
A large bank carries a duplication risk: repeated concepts and near-duplicate stems mean that by your second pass you may be recognising the wording rather than reasoning to the answer. Audit for this by noting how often the same concept recurs with a lightly changed wrapper. Some repetition is good spaced practice; too much turns "completion" into recognition and inflates your percentage. This is exactly why you should reserve a pool of unseen questions — ideally from a different source — for honest measurement, so that bank familiarity never masquerades as readiness.
Best-fit matrix: where this bank earns its place
| Use case | Fit for StudyPRN palliative bank |
|---|---|
| Foundation building | Reasonable, if you pair it with source reading on weak domains |
| First-pass primary bank | Strong — dedicated, sizeable, blueprint-relevant |
| Second bank | Workable, but watch for concept overlap with your first |
| Retake preparation | Strong, especially with its 100-question mock for pacing |
| Final simulation | Its timed mock helps; supplement with unseen mixed blocks for a clean readiness read |
The bank is at its best as a dedicated first-pass primary and as retake support; it is least suited to serving as your only measurement source, because you cannot measure yourself honestly on items you have already worked.
Worked example: a seven-day plan around clinical work
Using StudyPRN for one job — first-pass learning and review — and iatroX for unseen transfer measurement, with no proprietary-algorithm claims.
- Monday (45 min): StudyPRN block on symptom control (the 24% domain), timed; code misses.
- Tuesday (40 min): Pharmacology block; opioid-conversion calculation drill alongside.
- Wednesday (30 min): iatroX small unseen mixed block; log first-attempt accuracy by domain.
- Thursday (45 min): Emergencies and legal/ethics blocks; one source read on the Mental Capacity Act.
- Friday (20 min): Spaced review of oldest misses; recency check of two questions against current NICE guidance.
- Saturday (2 h): StudyPRN's 100-question timed mock for pacing; full error-coding.
- Sunday (40 min): iatroX unseen mixed block as the readiness check; rebuild the blueprint-coverage table.
StudyPRN carries the learning and the pacing rehearsal; iatroX is the unseen measurement layer that confirms transfer, per the two-Q-bank rule.
Decision checklist: continue, supplement, switch or stop
- Continue StudyPRN if its per-domain coverage matches the blueprint and your unseen accuracy is rising.
- Supplement with source reading or a second measurement bank where a heavy domain stays weak or duplication is creeping in.
- Switch only for a measurable coverage or currency gap — not for novelty.
- Stop first-pass work and move to mock-plus-unseen mode when your readiness conditions are met.
Bottom line
StudyPRN genuinely covers SCE Palliative Medicine, and for a niche exam that alone puts it ahead of general banks that skim the specialty. What it cannot do — by virtue of being a multiple-choice bank — is fully rehearse the calculations, the ethics reasoning and the formulary depth the blueprint's heavy domains demand, or measure you honestly once you have seen its questions. Use it as a strong first-pass primary, close the format gaps against primary guidance, and keep an unseen measurement layer alongside. Compare your options on the iatroX comparison hub.
FAQ
Is StudyPRN enough for SCE Palliative Medicine on its own? It is a strong primary and, for many candidates, close to sufficient when paired with official material and source reading — its dedicated palliative focus is a real advantage. What it cannot do alone is close the format gaps around symptom-control calculations and ethics reasoning, or measure your retention once you have seen every question, so plan to supplement those two things rather than rely on the bank in isolation.
Which SCE Palliative Medicine component does StudyPRN not reproduce well? The SCE is written-only, so nothing is structurally missing, but the elements a standard bank reproduces least well are the fluent opioid-conversion and syringe-driver calculations, the nuanced capacity and advance-decision reasoning, and the drug-level formulary detail grounded in the SmPC/eMC. These need deliberate calculation drills and source reading beyond answering multiple-choice items.
How many StudyPRN questions should I complete per day for SCE Palliative Medicine? Let review capacity set the pace — around 20–30 fully coded questions on a weekday with a longer weekend block suits most trainees working around clinical duties. With 599 questions including a mock (vendor-reported, 20 July 2026) you have plenty of volume, so the real constraint is whether each miss on the heavy symptom-control and pharmacology domains gets a proper corrective action.
When should I stop using StudyPRN and move to mixed mocks? Move to timed mixed practice — including StudyPRN's own 100-question mock — once every blueprint domain is above its attempted-and-reviewed floor and your unseen accuracy is stable across two checks, not when you hit 100% completion. Its mock is useful for pacing across a three-hour paper, but pair it with unseen mixed blocks so recognition of seen items does not inflate the read.
How should I combine StudyPRN with iatroX without duplicating practice? Give each a distinct role: StudyPRN for first-pass learning, review and timed pacing; iatroX for unseen, mixed measurement. iatroX is not a palliative-specific SCE bank — it is the cross-specialty knowledge and unseen-MCQ layer — so it answers "does this transfer?" without re-testing items you have already worked. Learning on one and measuring on the other is how the two-Q-bank rule keeps your calibration intact.
Editorial notes and references
Written by Dr Kolawole Tytler, NHS GP and founder of iatroX. Last checked 20 July 2026. Question counts, prices and the "frequently updated" claim are vendor-reported and change; confirm current figures on the StudyPRN product page before purchase. Disclosure: iatroX operates a competing question bank; its role here is confined to unseen cross-specialty measurement and spaced retrieval, jobs StudyPRN's palliative product does not claim to perform. Corrections are welcome via the feedback route on iatrox.com.
References: The Federation of the Royal Colleges of Physicians — SCE in Palliative Medicine specialty page and 2023 blueprint (thefederation.uk); StudyPRN Palliative Medicine SCE product page (studyprn.com); NICE (care of dying adults and symptom-specific guidance), SIGN and CKS, and the SmPC/eMC for medicines detail; iatroX internal references — Your Q-Bank Percentage Is Not Your Exam Score and question-bank completion is not coverage.